Presentations at the European Crohn’s and Colitis Organization annual meeting supported the transition to adalimumab biosimilars and provided patient acceptance data. CONTEXT: Among the poster presentations described in this article Continue Reading
CONTEXT: Publication of analysis from an ongoing 5-year longitudinal observational study of more than 4,400 patients with inflammatory bowel disease (IBD) in the Journal of Clinical Gastroenterology. This paper includes Continue Reading
CONTEXT: RWE data presented at the Digestive Disease Week (DDW) 2021 evaluated the prevalence and predictors of immunomodulator use as concomitant therapy with two commonly prescribed biologics. IMPACT: Low Continue Reading
